V028-2220 Screening compound: 4-(4-{2-[N-benzyl-1-(3-methoxyphenyl)formamido]acetamido}phenyl)-N-tert-butylpiperazine-1-carboxamide

V028-2220 Screening compound: 4-(4-{2-[N-benzyl-1-(3-methoxyphenyl)formamido]acetamido}phenyl)-N-tert-butylpiperazine-1-carboxamide
V028-2220 Screening compound: 4-(4-{2-[N-benzyl-1-(3-methoxyphenyl)formamido]acetamido}phenyl)-N-tert-butylpiperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V028-2220
4-(4-{2-[N-benzyl-1-(3-methoxyphenyl)formamido]acetamido}phenyl)-N-tert-butylpiperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V028-2220

Molecular Formula

C32H39N5O4 (C32 H39 N5 O4)

Compound Name

4-(4-{2-[N-benzyl-1-(3-methoxyphenyl)formamido]acetamido}phenyl)-N-tert-butylpiperazine-1-carboxamide

IUPAC name

4-(4-{2-[N-benzyl-1-(3-methoxyphenyl)formamido]acetamido}phenyl)-N-tert-butylpiperazine-1-carboxamide

SMILES

CC(C)(C)NC(N(CC1)CCN1c(cc1)ccc1NC(CN(Cc1ccccc1)C(c1cc(OC)ccc1)=O)=O)=O

InChI

InChI=1S/C32H39N5O4/c1-32(2,3)34-31(40)36-19-17-35(18-20-36)27-15-13-26(14-16-27)33-29(38)23-37(22-24-9-6-5-7-10-24)30(39)25-11-8-12-28(21-25)41-4/h5-16,21H,17-20,22-23H2,1-4H3,(H,33,38)(H,34,40)

InChI Key

AASIEDPOQITNIU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19813325

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

557.69

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.476

Distribution Coefficient, logD

4.454

Water Solubility, LogSw

-4.30

Polar Surface Area

76.018

Acid Dissociation Constant (pKa)

12.60

Base Dissociation Constant (pKb)

6.12

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.40

V028-2220 in Drug Discovery

Included in Screening Libraries

Lipid Metabolism Library (9174 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cardiovascular
  • Metabolic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Proteases
  • Phosphatases

References: we are preparing a list of scientific research reports with V028-2220 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V028-2220?
Check Price and Availability of V028-2220, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V028-2220 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V028-2220
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V028-2220
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V028-2220 available by request